# Ravicti

NDC: 75987-050
Generic name: glycerol phenylbutyrate
Labeler / Manufacturer: Horizon Therapeutics USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: LIQUID
Routes: ORAL
Marketing started: 20130228

FDA application: NDA203284

## Active ingredients

- GLYCEROL PHENYLBUTYRATE: 1.1 g/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"75987-050"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=75987-050
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=900e7dc0-9afe-4f50-80de-90567bb78519